《過敏性哮喘與臨床免疫學》(AACI)是加拿大變態反應與臨床免疫學學會(CSACI)的官方期刊，是一本涵蓋變態反應與免疫疾病的診斷、流行病學、預防與治療的所有方面的開放獲取期刊。AACI通過為新的見解和討論提供一個高能見度的論壇，為過敏和臨床免疫學研究和評論提供了一個平臺，在世界各地的過敏學家、肺病學家、免疫學家和其他醫生、衛生保健工作者、醫科學生和公眾之間傳播。AACI報告的基礎研究和臨床應用研究在以下領域和其他相關主題：哮喘與職業性肺病、鼻結膜炎與鼻竇炎、藥物過敏、過敏性皮膚病、蕁麻疹與血管水腫、毒液過敏、過敏反應與食物過敏、免疫治療、免疫調節劑與生物制劑、免疫缺陷與自身免疫、T細胞與B細胞功能、調節性T細胞、自然殺傷細胞、肥大細胞與嗜酸性粒細胞功能、補體異常。

Allergy Asthma and Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide.AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.